StockData
SELLAS Life Sciences Group, Inc. logo

SELLAS Life Sciences Group, Inc. (SLS) stock

SLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$19.15+11.68 (+156.36%)

Close on Nov 17, 2026Market cap $3.87BP/E –Yield –

SELLAS Life Sciences pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for SELLAS Life Sciences

SELLAS Life Sciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More SELLAS Life Sciences figures

See a number that looks wrong?